However, a recent study investigating the immunopeptidome of neuroblastoma shows that a QYNPIRTTF discovered on HLA-A*24:02, deriving from the master transcription regulator PHOX2B, can be targeted by constructing peptide-centric chimeric antigen receptors (PC-CARs) recognizing the PHOX2B-derived peptide. This evidence concerns the gene PHOX2B and neuroblastoma.